156 related articles for article (PubMed ID: 23063503)
1. Distinct profiles of oxidative stress-related and matrix proteins in adult bone and soft tissue osteosarcoma and desmoid tumors: a proteomics study.
Rao UN; Hood BL; Jones-Laughner JM; Sun M; Conrads TP
Hum Pathol; 2013 May; 44(5):725-33. PubMed ID: 23063503
[TBL] [Abstract][Full Text] [Related]
2. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
[TBL] [Abstract][Full Text] [Related]
3. Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas.
Coffin CM; Hornick JL; Zhou H; Fletcher CD
Am J Surg Pathol; 2007 Mar; 31(3):410-6. PubMed ID: 17325483
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
5. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
[TBL] [Abstract][Full Text] [Related]
6. Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors.
Hoos A; Lewis JJ; Antonescu CR; Dudas ME; Leon L; Woodruff JM; Brennan MF; Cordon-Cardo C
Cancer Res; 2001 Apr; 61(7):3171-5. PubMed ID: 11306504
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.
Verschoor AJ; Cleton-Jansen AM; Wijers-Koster P; Coffin CM; Lazar AJ; Nout RA; Rubin BP; Gelderblom H; Bovée JV
Am J Surg Pathol; 2015 Dec; 39(12):1701-7. PubMed ID: 26414222
[TBL] [Abstract][Full Text] [Related]
8. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma.
Gomez-Brouchet A; Mourcin F; Gourraud PA; Bouvier C; De Pinieux G; Le Guelec S; Brousset P; Delisle MB; Schiff C
Hum Pathol; 2010 Sep; 41(9):1220-30. PubMed ID: 20399482
[TBL] [Abstract][Full Text] [Related]
9. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets.
Folio C; Mora MI; Zalacain M; Corrales FJ; Segura V; Sierrasesúmaga L; Toledo G; San-Julián M; Patiño-García A
J Proteome Res; 2009 Aug; 8(8):3882-8. PubMed ID: 19492781
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma.
Kilpatrick SE; Geisinger KR; King TS; Sciarrotta J; Ward WG; Gold SH; Bos GD
Mod Pathol; 2001 Dec; 14(12):1277-83. PubMed ID: 11743051
[TBL] [Abstract][Full Text] [Related]
12. Expression of heat shock proteins in osteosarcomas.
Moon A; Bacchini P; Bertoni F; Olvi LG; Santini-Araujo E; Kim YW; Park YK
Pathology; 2010; 42(5):421-5. PubMed ID: 20632817
[TBL] [Abstract][Full Text] [Related]
13. Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.
Lenos K; Grawenda AM; Lodder K; Kuijjer ML; Teunisse AF; Repapi E; Grochola LF; Bartel F; Hogendoorn PC; Wuerl P; Taubert H; Cleton-Jansen AM; Bond GL; Jochemsen AG
Cancer Res; 2012 Aug; 72(16):4074-84. PubMed ID: 22700878
[TBL] [Abstract][Full Text] [Related]
14. Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisons.
McHugh JB; Thomas DG; Herman JM; Ray ME; Baker LH; Adsay NV; Rabah R; Lucas DR
Cancer; 2006 Aug; 107(3):554-62. PubMed ID: 16795069
[TBL] [Abstract][Full Text] [Related]
15. Does early colectomy increase desmoid risk in familial adenomatous polyposis?
Durno C; Monga N; Bapat B; Berk T; Cohen Z; Gallinger S
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1190-4. PubMed ID: 17916546
[TBL] [Abstract][Full Text] [Related]
16. Analysis of TGF-beta protein expression in aggressive fibromatosis (desmoid tumor).
Ferenc T; Stalińska L; Turant M; Sygut J; Tosik D; Dziki A; Kulig A
Pol J Pathol; 2006; 57(2):77-81. PubMed ID: 17019969
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of osteosarcoma cells identifies ALDOA and SULT1A3 as negative survival markers of human osteosarcoma.
Chen X; Yang TT; Zhou Y; Wang W; Qiu XC; Gao J; Li CX; Long H; Ma BA; Ma Q; Zhang XZ; Yang LJ; Fan QY
Mol Carcinog; 2014 Feb; 53(2):138-44. PubMed ID: 22949271
[TBL] [Abstract][Full Text] [Related]
18. Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target.
Colombo C; Creighton CJ; Ghadimi MP; Bolshakov S; Warneke CL; Zhang Y; Lusby K; Zhu S; Lazar AJ; West RB; van de Rijn M; Lev D
J Pathol; 2011 Dec; 225(4):574-82. PubMed ID: 21826666
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
20. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
